- Home
- MCRB vs GEG Comparison
MCRB vs GEG Comparison
Compare MCRB & GEG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MCRB | GEG |
|---|---|---|
| Founded | 2010 | 1994 |
| Country | United States | United States |
| Employees | N/A | 50 |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 71.0M | 69.0M |
| IPO Year | 2015 | N/A |
Fundamental Metrics
Financial Performance| Metric | MCRB | GEG |
|---|---|---|
| Price | $7.14 | $2.28 |
| Analyst Decision | Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $14.00 | N/A |
| AVG Volume (30 Days) | ★ 111.9K | 15.4K |
| Earning Date | 05-11-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $789,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $5.31 | $1.80 |
| 52 Week High | $29.98 | $3.51 |
Technical Indicators
Market Signals| Indicator | MCRB | GEG |
|---|---|---|
| Relative Strength Index (RSI) | 47.54 | 48.10 |
| Support Level | $6.56 | $1.97 |
| Resistance Level | $9.53 | $2.23 |
| Average True Range (ATR) | 0.60 | 0.17 |
| MACD | 0.07 | -0.03 |
| Stochastic Oscillator | 45.29 | 8.89 |
Price Performance
Historical ComparisonAbout MCRB Seres Therapeutics Inc.
Seres Therapeutics Inc is a clinical-stage biotechnology company focused on the development of live biotherapeutic candidates. Its pipeline includes candidates such as SER-155 and SER-603, aimed at preventing and treating bacterial infections, antimicrobial resistance, and gastrointestinal immune diseases. The company operates as a single reportable segment, mainly developing microbiome-based therapies targeting bacterial infections, antimicrobial resistance, and gastrointestinal immune diseases.
About GEG Great Elm Group Inc.
Great Elm Group Inc operates as an alternative asset manager focused on growing a scalable and diversified portfolio of long-duration and permanent capital vehicles across credit, real estate, specialty finance, and other alternative strategies. Along with its subsidiaries, it manages Great Elm Capital Corp, a publicly traded business development company, and Monomoy Properties REIT, LLC, an industrial-focused real estate investment trust, in addition to other investments.